Medytox is a research-based bio pharmaceutical company which developed a botulinum toxin product for the first time in Korea (the fourth in the world), and engages in the development, manufacture, marketing, and sales of neurotoxin products as its main business. Since its establishment in 2000, Medytox has developed and evolved into a global world-class R&D company with the successful launch of its main neurotoxin product. Today, Medytox's neurotoxin products are sold in about 60 countries with millions of people having already received therapeutic or aesthetic treatments.
View Top Employees from Medy-Tox Inc.| Website | http://www.medy-tox.co.kr |
| Revenue | $184 million |
| Employees | View employees |
| Founded | 2000 |
| Address | 78 Gangni 1-gil Ochang-eup, Cheongju-si, Chungcheongbuk-do, KR |
| Phone | +82 43-217-1555 |
| Fax | +82 43-217-1557 |
| Industry | Business Services General, Pharmaceuticals, Business Services, Other Pharmaceuticals and Biotechnology |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Medy-Tox Inc. employee's phone or email?
Medy-Tox Inc. Questions
The Medy-Tox Inc. annual revenue was $184 million in 2024.
Medy-Tox Inc. is based in Cheongju-si, Chungcheongbuk-do.
The NAICS codes for Medy-Tox Inc. are [541713, 5417, 541, 54, 54171].
The SIC codes for Medy-Tox Inc. are [87, 873].
